TAMOXIFILM 20 is a prescription medicine formulated with Tamoxifen 20 mg, a selective estrogen receptor modulator (SERM) widely used in the management and prevention of hormone receptor-positive breast cancer. Tamoxifen works by blocking estrogen, a hormone that promotes the growth of certain types of breast cancer cells.
Manufactured under strict quality standards, TAMOXIFILM 20 is a trusted choice for patients requiring long-term therapy for breast cancer treatment or risk reduction. It is commonly recommended by oncologists and healthcare professionals as part of comprehensive breast cancer management.
Uses
TAMOXIFILM 20 is primarily used for:
Treatment of Hormone Receptor-Positive Breast Cancer
Helps slow or stop the growth of estrogen-sensitive breast tumors in pre- and post-menopausal women.
Prevention of Breast Cancer
Reduces the risk of developing breast cancer in women at high risk due to family history or genetic predisposition.
Management of Advanced or Metastatic Breast Cancer
Used alone or in combination with other therapies to control the disease and improve patient outcomes.
Fertility-Related Indications (Off-label Use)
Occasionally prescribed for ovulation induction in certain fertility treatments under strict medical supervision.
Benefits
1. Blocks Estrogen Effectively
Tamoxifen binds to estrogen receptors on cancer cells, preventing estrogen from stimulating tumor growth.
2. Reduces Recurrence Risk
Long-term use significantly lowers the chance of breast cancer returning after initial treatment.
3. Preventive Therapy for High-Risk Patients
Women with a family history of breast cancer or genetic mutations (BRCA1/2) benefit from decreased incidence.
4. Oral Administration
Convenient tablet form allows easy daily use, improving treatment adherence.
5. Clinically Proven
Tamoxifen has been used for decades and supported by extensive clinical research for safety and efficacy.
Dosage
The typical recommended dose of TAMOXIFILM 20 is one 20 mg tablet daily, unless otherwise prescribed by the doctor.
Duration of therapy may vary depending on the patient’s condition and risk profile, often extending 5–10 years for preventive or adjuvant therapy.
Tablets should be swallowed whole with water and taken at the same time each day for best results.
Important: Never adjust the dosage without consulting a healthcare professional.
Side Effects
Most patients tolerate TAMOXIFILM 20 well, but some may experience mild to moderate side effects, including:
Hot flashes or flushing
Nausea or vomiting
Fatigue or dizziness
Vaginal dryness or discharge
Menstrual irregularities
Serious Side Effects (Rare)
Blood clots or deep vein thrombosis
Stroke
Endometrial changes or uterine cancer in long-term use
Vision changes
Seek immediate medical attention if any severe or unusual symptoms occur.
Precautions and Warning
Pregnancy and Breastfeeding: Tamoxifen should not be used during pregnancy and caution is advised during breastfeeding.
History of Blood Clots: Patients with prior clotting disorders should inform their doctor before starting therapy.
Liver Disease: Liver function may need to be monitored, especially during long-term therapy.
Drug Interactions: Inform your physician about all other medications, including anticoagulants, corticosteroids, or hormone therapies.
Regular Checkups: Routine follow-ups, including mammograms and gynecological exams, are essential during treatment.
Conclusion
TAMOXIFILM 20 (Tamoxifen 20 mg) is a trusted and effective therapy for hormone receptor-positive breast cancer management and prevention. Its targeted action against estrogen-sensitive cells helps reduce tumor growth, prevent recurrence, and provide long-term protection for high-risk patients.
When used under medical supervision and following the prescribed dosage, TAMOXIFILM 20 offers a safe and reliable option for improving breast cancer outcomes and supporting patient health with proven clinical benefits.
Reviews
There are no reviews yet.